Log in
Enquire now
‌

US Patent 11352355 Solid state forms of fused heteroaromatic pyrrolidinones

Patent 11352355 was granted and assigned to Calithera Biosciences on June, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Calithera Biosciences
Calithera Biosciences
Current Assignee
Calithera Biosciences
Calithera Biosciences
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11352355
Date of Patent
June 7, 2022
Patent Application Number
16870653
Date Filed
May 8, 2020
Patent Citations
‌
US Patent 10676473 Solid state forms of fused heteroaromatic pyrrolidinones
Patent Primary Examiner
‌
James D. Anderson
CPC Code
‌
A61K 9/20
‌
A61K 9/48
‌
C07D 471/04

Disclosed are chemical entities which are inhibitors of spleen tyrosine kinase (SYK), namely, chemical entities comprising 6-((1R,2S)-2-aminocyclohexylamino)-7-fluoro-4-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,4-c]pyridine-3(2H)-one and certain solid state forms thereof. Also disclosed are methods of using the chemical entities to treat disorders such as a cancer.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11352355 Solid state forms of fused heteroaromatic pyrrolidinones

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.